AllianceBernstein
SONM icon

AllianceBernstein’s DNA X Inc SONM Stock Holding History

AllianceBernstein’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7
Closed -$8K – 3253
2020
Q1 		$8K Buy
+7
New +$33.5K ﹤0.01% 3124

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

AllianceBernstein's SONM Position: Q2 2020 in Review

AllianceBernstein sold out of DNA X Inc (SONM) in Q2 2020, closing a stake of 7 shares — an estimated $8K sold.

AllianceBernstein first reported a position in SONM in Q1 2020 and held it in 1 quarter. The position peaked at $8K in Q1 2020. 39 funds tracked by Wall St. Rank hold SONM as of Q2 2020.

  • AllianceBernstein reported no remaining DNA X Inc position as of Q2 2020 after selling out during the quarter.
  • AllianceBernstein sold 7 DNA X Inc shares in Q2 2020, an estimated $8K.
  • AllianceBernstein first reported a position in DNA X Inc in Q1 2020 and held it in 1 quarter.
  • AllianceBernstein's DNA X Inc position peaked at $8K in Q1 2020.
  • 39 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2020.

Based on AllianceBernstein's 13F filing for Q2 2020, filed 13 Aug 2020.